Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study
BackgroundIn routine clinical practice, chemotherapy doses are frequently capped at a body surface area (BSA) of 2.0 m2 or adjusted to an ideal weight for obese patients due to safety reasons.Materials and methodsBetween August 2004 and July 2008, a total of 3023 patients were enrolled in the GAIN s...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
8 August 2016
|
| In: |
Annals of oncology
Year: 2016, Jahrgang: 27, Heft: 11, Pages: 2053-2059 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdw315 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/annonc/mdw315 Verlag, kostenfrei, Volltext: https://academic.oup.com/annonc/article/27/11/2053/2440231/Higher-rate-of-severe-toxicities-in-obese-patients 
|
| Verfasserangaben: | J. Furlanetto, W. Eiermann, F. Marmé, T. Reimer, M. Reinisch, S. Schmatloch, E. Stickeler, C. Thomssen, M. Untch, C. Denkert, G. von Minckwitz, B. Lederer, V. Nekljudova, K. Weber, S. Loibl and V. Möbus |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1564515141 | ||
| 003 | DE-627 | ||
| 005 | 20230920090720.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 171018s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdw315 |2 doi | |
| 035 | |a (DE-627)1564515141 | ||
| 035 | |a (DE-576)494515147 | ||
| 035 | |a (DE-599)BSZ494515147 | ||
| 035 | |a (OCoLC)1340980717 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Furlanetto, Jenny |e VerfasserIn |0 (DE-588)1141798654 |0 (DE-627)1000750841 |0 (DE-576)494512636 |4 aut | |
| 245 | 1 | 0 | |a Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area |b results of the prospectively randomized GAIN study |c J. Furlanetto, W. Eiermann, F. Marmé, T. Reimer, M. Reinisch, S. Schmatloch, E. Stickeler, C. Thomssen, M. Untch, C. Denkert, G. von Minckwitz, B. Lederer, V. Nekljudova, K. Weber, S. Loibl and V. Möbus |
| 264 | 1 | |c 8 August 2016 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.10.2017 | ||
| 520 | |a BackgroundIn routine clinical practice, chemotherapy doses are frequently capped at a body surface area (BSA) of 2.0 m2 or adjusted to an ideal weight for obese patients due to safety reasons.Materials and methodsBetween August 2004 and July 2008, a total of 3023 patients were enrolled in the GAIN study, a randomized phase III adjuvant trial, comparing two types of dose-dense (dd) regimen [epirubicin, docetaxel and cyclophosphamide (iddETC) versus epirubicin and cyclophosphamide (EC) followed by docetaxel (T) plus capecitabine (X)]. We retrospectively evaluated a total of 555 patients with a BMI of ≥30 for safety and outcome.ResultsEighteen percent of all patients were obese: 31% of those received chemotherapy according to an unadjusted BSA. For the remaining patients, BSA was adjusted to ideal weight or was capped at 2.0 m2. A total of 15% of obese patients receiving full (unadjusted) dose of chemotherapy versus 6% of obese patients with an adjusted BSA experienced febrile neutropenia (P = 0.003) and 9% versus 3% high-grade thrombopenia (P = 0.002). Overall, 17% versus 10% had a thromboembolic event (P = 0.017), which was high grade in 13% versus 6%, respectively (P = 0.019), and 3% versus 0.3% high-grade hot flushes (P = 0.013). Dizziness (5% versus 11%; P = 0.016), diarrhea (19% versus 27%; P = 0.033) and an increase in serum creatinine (7% versus 14%; P = 0.019) were higher in the adjusted group. However, no differences in disease-free survival (DFS) and overall survival (OS) were observed between non-obese patients, obese patients receiving full-dose chemotherapy or according to an adjusted BSA [5-year DFS 81% (confidence interval 79% to 83%) versus 82% (75% to 87%) versus 81% (76% to 84%); P = 0.761; 5-year OS 90% (88% to 91%) versus 86% (80% to 91%) versus 88% (84% to 91%); P = 0.143].ConclusionObese patients receiving dd chemotherapy according to their real BSA have a higher risk of developing severe toxicities without influencing survival. Therefore, a dose adjustment of intense dd chemotherapy should be carried out to avoid life-threatening complications. | ||
| 700 | 1 | |a Eiermann, Wolfgang |e VerfasserIn |0 (DE-588)1038176131 |0 (DE-627)756738911 |0 (DE-576)175561699 |4 aut | |
| 700 | 1 | |a Marmé, Frederik |d 1974- |e VerfasserIn |0 (DE-588)132561972 |0 (DE-627)52394893X |0 (DE-576)299226549 |4 aut | |
| 700 | 1 | |a Reimer, Toralf |d 1968- |e VerfasserIn |0 (DE-588)114954453 |0 (DE-627)486911314 |0 (DE-576)289814138 |4 aut | |
| 700 | 1 | |a Reinisch, Mattea |e VerfasserIn |0 (DE-588)1158691483 |0 (DE-627)1020763825 |0 (DE-576)504303635 |4 aut | |
| 700 | 1 | |a Schmatloch, Sabine |d 1971- |e VerfasserIn |0 (DE-588)123334314 |0 (DE-627)706260341 |0 (DE-576)29366109X |4 aut | |
| 700 | 1 | |a Stickeler, Elmar |d 1965- |e VerfasserIn |0 (DE-588)1110784147 |0 (DE-627)86516584X |0 (DE-576)475779843 |4 aut | |
| 700 | 1 | |a Thomssen, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Untch, Michael |e VerfasserIn |0 (DE-588)134268083 |0 (DE-627)566077914 |0 (DE-576)300413572 |4 aut | |
| 700 | 1 | |a Denkert, Carsten |d 1969- |e VerfasserIn |0 (DE-588)118129929 |0 (DE-627)079261124 |0 (DE-576)291730604 |4 aut | |
| 700 | 1 | |a Minckwitz, Gunter von |d 1964- |e VerfasserIn |0 (DE-588)172260035 |0 (DE-627)673296962 |0 (DE-576)133128202 |4 aut | |
| 700 | 1 | |a Lederer, B. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nekljudova, Valentina |d 1973- |e VerfasserIn |0 (DE-588)129732125 |0 (DE-627)478568959 |0 (DE-576)297809113 |4 aut | |
| 700 | 1 | |a Weber, K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Loibl, S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Möbus, Volker |d 1953- |e VerfasserIn |0 (DE-588)1121145272 |0 (DE-627)874014891 |0 (DE-576)480748489 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 27(2016), 11, Seite 2053-2059 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area results of the prospectively randomized GAIN study |
| 773 | 1 | 8 | |g volume:27 |g year:2016 |g number:11 |g pages:2053-2059 |g extent:7 |a Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area results of the prospectively randomized GAIN study |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/annonc/mdw315 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/annonc/article/27/11/2053/2440231/Higher-rate-of-severe-toxicities-in-obese-patients |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20171018 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 132561972 |a Marmé, Frederik |m 132561972:Marmé, Frederik |d 910000 |d 910400 |e 910000PM132561972 |e 910400PM132561972 |k 0/910000/ |k 1/910000/910400/ |p 3 | ||
| 999 | |a KXP-PPN1564515141 |e 2984569385 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"role":"aut","given":"Jenny","display":"Furlanetto, Jenny","family":"Furlanetto"},{"family":"Eiermann","display":"Eiermann, Wolfgang","role":"aut","given":"Wolfgang"},{"display":"Marmé, Frederik","family":"Marmé","role":"aut","given":"Frederik"},{"given":"Toralf","role":"aut","family":"Reimer","display":"Reimer, Toralf"},{"role":"aut","given":"Mattea","family":"Reinisch","display":"Reinisch, Mattea"},{"given":"Sabine","role":"aut","display":"Schmatloch, Sabine","family":"Schmatloch"},{"family":"Stickeler","display":"Stickeler, Elmar","role":"aut","given":"Elmar"},{"given":"C.","role":"aut","display":"Thomssen, C.","family":"Thomssen"},{"display":"Untch, Michael","family":"Untch","given":"Michael","role":"aut"},{"family":"Denkert","display":"Denkert, Carsten","given":"Carsten","role":"aut"},{"given":"Gunter von","role":"aut","family":"Minckwitz","display":"Minckwitz, Gunter von"},{"display":"Lederer, B.","family":"Lederer","role":"aut","given":"B."},{"given":"Valentina","role":"aut","display":"Nekljudova, Valentina","family":"Nekljudova"},{"display":"Weber, K.","family":"Weber","given":"K.","role":"aut"},{"role":"aut","given":"S.","family":"Loibl","display":"Loibl, S."},{"display":"Möbus, Volker","family":"Möbus","role":"aut","given":"Volker"}],"relHost":[{"part":{"text":"27(2016), 11, Seite 2053-2059","issue":"11","year":"2016","pages":"2053-2059","volume":"27","extent":"7"},"language":["eng"],"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"id":{"zdb":["2003498-2"],"issn":["1569-8041"],"eki":["320428796"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"320428796","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area results of the prospectively randomized GAIN studyAnnals of oncology","note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"pubHistory":["1.1990 -"],"origin":[{"publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedKey":"1990","dateIssuedDisp":"1990-","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford"}],"title":[{"subtitle":"official journal of the European Society for Medical Oncology","title_sort":"Annals of oncology","title":"Annals of oncology"}]}],"recId":"1564515141","physDesc":[{"extent":"7 S."}],"name":{"displayForm":["J. Furlanetto, W. Eiermann, F. Marmé, T. Reimer, M. Reinisch, S. Schmatloch, E. Stickeler, C. Thomssen, M. Untch, C. Denkert, G. von Minckwitz, B. Lederer, V. Nekljudova, K. Weber, S. Loibl and V. Möbus"]},"id":{"eki":["1564515141"],"doi":["10.1093/annonc/mdw315"]},"title":[{"title":"Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area","subtitle":"results of the prospectively randomized GAIN study","title_sort":"Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area"}],"origin":[{"dateIssuedDisp":"8 August 2016","dateIssuedKey":"2016"}],"note":["Gesehen am 18.10.2017"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a FURLANETTOHIGHERRATE8201 | ||